APRES THERAPEUTICS
Apres Therapeutics is a biotechnology company. The company is based in Wilmington, Delaware.
APRES THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2019-07-10
Address:
Wilmington, Delaware, United States
Country:
United States
Status:
Active
Similar Organizations
AmStem
AmStem operates as a biotechnology company.
InnovATEBIO
InnovATEBIO is a Biotechnology company.
GenHunter Corporation
A biotechnology company .
Mperia Therapeutics
Mperia Therapeutics is a biotechnology company.
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Trigenesis Therapeutics
Trigenesis Therapeutics is a Biotechnology company.
Xios Therapeutics
Xios Therapeutics is a biotechnology company .
More informations about "Apres Therapeutics"
Apres Therapeutics - Funding, Financials, Valuation & Investors
Organization. Apres Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Funding Rounds 1. Funding. Apres …See details»
Apres Therapeutics - Crunchbase
Apres Therapeutics, RNADerm Therapeutics, Trigenesis Therapeutics, Xios Therapeutics, Mperia Therapeutics, and InnovATEBIO are all part of the biotechnology industry. RNADerm, …See details»
Apres Therapeutics - Overview, News & Similar companies
Apres Therapeutics Inc is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. The company is headquartered in Boston, …See details»
Apres Therapeutics , Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 19, 2023 0 Patents (Medical) associated with Apres Therapeutics , Inc. Login to view more data. Pipeline. Pipeline Snapshot as of 19 Jun 2023. No pipeline posted. Login to keep …See details»
About - Abcuro
Jeff has deep expertise in the areas of immunology, rare diseases, and immuno-oncology. He has served in senior clinical leadership positions, including as Chief Medical Officer for over 20 years. Among others, Jeff led clinical development …See details»
Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied …
Aug 30, 2023 Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVAâ„¢ (ACER-001) with Acer Therapeutics. Relief Therapeutics Holding SA / Key …See details»
Regulation of gene expression by the APP family in the adult
Jan 7, 2022 In particular, the extracellular structure organization, calcium ion regulated exocytosis, and inhibitory postsynaptic potential were top enriched pathways in biological …See details»
Aprea Therapeutics | DDR-Targeted Therapy
Aprea Therapeutics focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Skip to content Aprea Therapeutics Reports Third …See details»
Apogee Therapeutics | Best-in-Class Therapies for …
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and …See details»
Relief and APR Applied Pharma Research Sign and …
Transforms Relief into a fully integrated commercial-stage biopharmaceutical company Acquisition further diversifies Relief’s pipeline with both commercial products and clinical-stage programs and provides a commercial infrastructure …See details»
New study setting the stage for non-opioid analgesic in
AmacaThera, a clinical-stage biotechnology company transforming therapeutics, is developing AMT-143, a long-acting formulation of a non-opioid analgesic designed to be placed directly at …See details»
New study setting the stage for non-opioid analgesic in post …
July 5, 2023 (Toronto, ON) — Patients are often prescribed opioids after undergoing surgical care to help them manage their post-surgical pain. This intervention often leads to dependency and …See details»
Apres Therapeutics - Updates, News, Events, Signals & Triggers
Apres Therapeutics is a biotechnology company. Recent News & Activity. Edit Recent News & Activity SectionSee details»
Nutcracker Therapeutics Presents Precision Biomanufacturing and …
4 days ago EMERYVILLE, Calif., November 25, 2024--Nutcracker Therapeutics will introduce its CRDMO capabilities to provide scalable biomanufacturing services for RNA drug developers.See details»
AmacaThera doses First In Human Study to Evaluate,… | AmacaThera
May 15, 2024 AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides …See details»
AmacaThera Closes Series A Extension to Advance Clinical
AmacaThera Inc., a resident company of Johnson & Johnson Innovation, JLABS @ Toronto is a clinical-stage company transforming therapeutics to make a difference in patient health. …See details»
Relief and Applied Pharma Research (APR) Sign Binding Term …
Acquisition would further diversify Relief’s pipeline with both commercial products and clinical-stage programs Geneva and Balerna, Switzerland, May 4, 2021 – RELIEF THERAPEUTICS …See details»
Antibe Changes Plans for Painkiller Otenaproxesul. And Not for …
Oct 14, 2021 Antibe Therapeutics has been developing otenaproxesul, a "miracle drug" that, at least in early trials, controlled both pain and inflammation -- but without the side effects of …See details»
New antibody therapy may reverse diabetic retinopathy and other …
Jun 9, 2021 With the antibody’s promising preclinical results, AntlerA Therapeutics will now lead the commercialization and translation to clinical studies. While the current study’s results are …See details»
Phaxiam Therapeutics vise la rentabilité en 2027 grâce au marché …
2 days ago (AOF) - Phaxiam Therapeutics prévoit "d'atteindre la rentabilité opérationnelle et un cash-flow disponible positif en 2027", grâce à une stratégie...See details»